Missedย NVDA?
Donโt Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Meihua International Medical Technologies Co., Ltd. (MHUA) Stock Forecast & Price Prediction China | NASDAQ | Healthcare | Medical Instruments & Supplies
$8.36
-0.51 (-5.75%)Did MHUA Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Meihua International is one of their latest high-conviction picks.
MHUA has shown a year-to-date change of 307.8% and a 1-year change of -72.9%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for MHUA. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for MHUA.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
The following stocks are similar to Meihua International based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Meihua International Medical Technologies Co., Ltd. has a market capitalization of $467.36M with a P/E ratio of 0.2x. The company generates $89.55M in trailing twelve-month revenue with a 10.4% profit margin.
Revenue growth is -16.2% quarter-over-quarter, while maintaining an operating margin of +8.5% and return on equity of +5.9%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Designs and manufactures medical devices.
The company generates revenue by designing, manufacturing, and distributing essential medical equipment and disposable products such as syringes and infusion sets. It serves a global market, supplying hospitals, clinics, and healthcare providers while ensuring product safety and efficacy through advanced technology and quality control.
Meihua International is recognized for its innovation and reliable distribution network. As demand for quality healthcare increases, the company maintains a significant market position, adapting to the needs of medical professionals and patients.
Healthcare
Medical Instruments & Supplies
619
Ms. Lee Leyi
China
2022
U.S. stock futures are mixed, with Dow futures declining approximately 0.1% this morning.
Mixed U.S. stock futures indicate market uncertainty, which may signal volatility ahead. A declining Dow futures could affect investor sentiment and trading strategies.
Meihua International Medical Technologies (Nasdaq: MHUA) will be delisted from Nasdaq due to non-compliance with Listing Rule 5550(a)(2), as announced on December 2, 2025.
Meihua's delisting from Nasdaq indicates financial instability, potentially reducing investor confidence and liquidating share value, impacting overall market perception of the company.
Meihua International Medical Technologies will conduct a 1-for-100 reverse share split and implement a dual-class share structure, effective November 24, 2025.
The reverse share split and dual-class structure may affect share liquidity and voting power, potentially influencing stock performance and investor sentiment regarding Meihua.
Meihua International Medical Technologies (Nasdaq: MHUA) reported its financial results for the fiscal year ending December 31, 2024.
Meihua International's fiscal results reveal its financial health and operational performance, influencing investor confidence and potential stock valuation.
Meihua International Medical Technologies Co., Ltd. (Nasdaq: MHUA) has regained compliance with Nasdaq's minimum bid price requirement as of October 3, 2024.
Meihua International's compliance with Nasdaq's minimum bid price requirement signals stability and potential recovery, positively influencing investor confidence and stock performance.
Meihua International Medical Technologies Co., Ltd. is based in Yangzhou, China, as reported on September 20, 2024. Further details on the company's activities were not provided.
Meihua International's announcement may signal developments in the medical technology sector, potentially impacting stock performance and investment opportunities in related companies.
Analyst forecasts for Meihua International Medical Technologies Co., Ltd. (MHUA) are not currently available. The stock is trading at $8.36.
Analyst ratings for MHUA are not currently available. The stock is currently trading at $8.36. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
Price predictions from Wall Street analysts for MHUA are not currently available. The stock is trading at $8.36.
The company generates revenue by designing, manufacturing, and distributing essential medical equipment and disposable products such as syringes and infusion sets. It serves a global market, supplying hospitals, clinics, and healthcare providers while ensuring product safety and efficacy through advanced technology and quality control.
Price targets from Wall Street analysts for MHUA are not currently available. The stock is trading at $8.36.
Price targets from Wall Street analysts for MHUA are not currently available. The stock is trading at $8.36.
Analyst ratings for MHUA are not currently available. The stock is trading at $8.36.
Stock price projections, including those for Meihua International Medical Technologies Co., Ltd., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.